Back to Home

Payment Integrity

Expert articles and analysis related to payment integrity.

197 articles•Last 30 Days

AI Summary — Last 30 Days

Payment integrity is shifting from retrospective recovery to prospective utilization and coding control: HHS OIG audits of HumanaChoice and UnitedHealthcare of Wisconsin found MA diagnosis-code submissions driving nearly $180 million in alleged overpayments, while the $541.5 million Villages Health settlement signals escalating False Claims Act risk for provider organizations participating in MA risk-adjustment workflows (Healthcare Dive). At the same time, CMMI under Abe Sutton is positioning the WISeR prior authorization model as a template for broader Medicare payment-integrity interventions, creating a strategic tension for ACOs and VBC providers between reducing low-value care and absorbing new administrative, documentation, and technology burdens (HFMA). For payers and risk-bearing providers, the through-line is clear: coding accuracy, evidence-backed diagnoses, and defensible utilization management are becoming core operating capabilities—not back-office compliance functions.

Related Articles

95ALN

The Next Era of Payment Integrity is Prevention, Not Recovery

The following is a guest article by Anne Neal, Vice President of Product Management for Payment Accuracy at Availity As Payment Integrity Programs Face Rising Administrative and Provider Friction, the...

Healthcare IT TodayAug 31, 2026
92ALN

CMS Oversight Did Not Prevent Medicare Part D Sponsors From Making $587.7 Million in Ineligible Payments to Pharmacies for Drugs Available Over the Counter but Labeled as Prescription-Only - Office of Inspector General (.gov)

CMS Oversight Did Not Prevent Medicare Part D Sponsors From Making $587.7 Million in Ineligible Payments to Pharmacies for Drugs Available Over the Counter but Labeled as Prescription-Only  Office of ...

OIG HHSSep 2, 2026
90ALN

From reactive denial management to upstream prevention

Denials are usually discovered after adjudication. The revenue loss, however, often begins much earlier. Hospitals continue to invest significant time and resources in denial management, yet roughly 1...

HFMASep 7, 2026
90ALN

7 Medicare Fraud Red Flags Seniors Should Watch for After CMS Blocked $1.6 Billion in Payments - savingadvice.com

7 Medicare Fraud Red Flags Seniors Should Watch for After CMS Blocked $1.6 Billion in Payments  savingadvice.com

news.google.comSep 7, 2026
90ALN

OIG: Medicare Part D plans spent millions on ineligible drugs

OIG: Medicare Part D plans spent millions on ineligible drugs  Fierce Healthcare

Fierce HealthcareSep 3, 2026
90ALN

For 4 Years, The Villages' Top Health Provider Allegedly Filed False Medicare Codes. The Bill Just Came Due: $541.5 Million. - 24/7 Wall St.

For 4 Years, The Villages' Top Health Provider Allegedly Filed False Medicare Codes. The Bill Just Came Due: $541.5 Million.  24/7 Wall St.

news.google.comSep 3, 2026
90ALN

Conflicting CMS Guidance and Federal Statutory Requirements Cost Medicare $380 Million Over a 6-Year Period for Organs Not Transplanted Into Medicare Enrollees - oig.hhs.gov

Conflicting CMS Guidance and Federal Statutory Requirements Cost Medicare $380 Million Over a 6-Year Period for Organs Not Transplanted Into Medicare Enrollees  oig.hhs.gov

OIG HHSSep 3, 2026
90ALN

Catching Errors Before Claims Go Out: How Mature Home Health Agencies Prevent Billing Mistakes

Home Health Care NewsSep 2, 2026
90ALN

Medicare spent hundreds of millions of dollars on ineligible drugs, audit finds

Shoddy CMS oversight is to blame, and the agency needs to do better, the HHS Office of the Inspector General said. The CMS concurred.

Healthcare DiveSep 2, 2026
90ALN

CMS Oversight Did Not Prevent Medicare Part D Sponsors From Making $587.7 Million in Ineligible Payments to Pharmacies for Drugs Available Over the Counter but Labeled as Prescription-Only - Office of Inspector General (.gov)

CMS Oversight Did Not Prevent Medicare Part D Sponsors From Making $587.7 Million in Ineligible Payments to Pharmacies for Drugs Available Over the Counter but Labeled as Prescription-Only  Office of ...

OIG HHSSep 2, 2026